Emergent BioSolutions: Down 40%+ From Recent Highs And Likely More To Come
Source: SeekingAlpha
2026-06-08 17:27:36 ET
Emergent BioSolutions Inc. ( EBS ) was founded in 1998 and is based in Gaithersburg, MD. It describes itself as ‘a global life sciences company focused on providing innovative preparedness and response solutions addressing accidental, deliberate, and naturally occurring Public Health Threats.’ Emergent has 11 products, with its business spread across three distinct segments:
- Commercial products, consisting of Narcan 4mg nasal spray and Kloxxado 8mg nasal spray to treat opioid (esp. fentanyl) overdosing;
- Medical counter-measures (MCM) products, consisting of vaccines and treatments for Anthrax and Smallpox, predominantly, alongside also Mpox, Botulism, and Ebola;
- Bioservices offerings.
Read the full article on Seeking Alpha
For further details see:
Emergent BioSolutions: Down 40%+ From Recent Highs And Likely More To Come
Amneal Pharmaceuticals Inc.
NASDAQ: AMRX
AMRX Trading
-2.64% G/L:
$17.54 Last:
756,552 Volume:
$17.86 Open:
AMRX Latest News
$4,628,993,997
156,741,352
0.09%
93
N/A
Pharmaceuticals
Healthcare
US
Bridgewater
